Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BCTX stock hub

BriaCell Therapeutics Corp. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BCTX

In the news

Latest news · BCTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-179.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-114.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001610820
Company name	BriaCell Therapeutics Corp.
Country	Canada
Country code	US
Cusip	107930307
Employees	16
Employees Change	10%
Employees Change Percent	166.7
Enterprise value	$22,390
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA1079303071
Last refreshed	2026-05-10
Market cap	$30.3M
Market cap category	Nano-Cap
Price	$4.19
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	BCTX
Website	https://briacell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-97.66%
FCF yield	-102.04%
P/B ratio	1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-29.6M
Net Income Growth Years	0%
Profit Per Employee	$-1.9M
ROA	-89.44
Roa5y	-65.05
ROCE	-101.1
ROE	-179.2
ROIC	-114.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-52.64%
Cagr1y	-87.2%
Cagr3y	-84.13%
Cagr5y	-61.5%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$33.6M
Cash	$29.9M
Current Assets	$32.2M
Current Liabilities	$3.2M
Equity	$30.2M
Interest Coverage	-831.2
Liabilities	$3.4M
Long Term Assets	$1.4M
Long Term Liabilities	$195,096
Net Cash	$29.9M
Net Cash By Market Cap	$98.53
Net Cash Growth	496.44%
Net Debt Equity	$-0.99
Tangible Book Value	$30.7M
Tangible Book Value Per Share	$4.24
WACC	13.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.1
Net Working Capital	$-910,294
Quick ratio	9.39
Working Capital	$29M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-784.7%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.94%
1Y total return	-87.19%
200-day SMA	7.31
3Y total return	-99.6%
50-day SMA	4.15
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.15%
All Time High	14,400.1
All Time High Change	-99.97%
All Time High Date	2015-04-22
All Time Low	3.6
All Time Low Change	16.39%
All Time Low Date	2026-02-24
ATR	0.23
Beta	1.63
Ch YTD	-41.07
High	4.2
High52	37.2
High52 Date	2025-05-21
High52ch	-88.74%
Low	4.05
Low52	3.6
Low52 Date	2026-02-24
Low52ch	16.39%
Ma50ch	0.89%
Premarket Change Percent	1.57
Premarket Price	$4.16
Premarket Volume	1,055
Price vs 200-day SMA	-42.65%
RSI	51.4
RSI Monthly	32.43
RSI Weekly	34.37
Sharpe ratio	-0.78x
Sortino ratio	-0.92
Total Return	-784.7%
Tr YTD	-41.07
Tr1m	-5.42%
Tr1w	0.24%
Tr3m	0.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Operating Income	$-30.7M
Price target	$40
Price Target Change	$855

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,410,284%
Float Percent	88.41%
Shares Insiders	2.52%
Shares Institutions	3.24%
Shares Out	7,250,487
Shares Qo Q	48.75%
Shares Yo Y	784.7%
Short Float	3.54%
Short Ratio	1.35
Short Shares	3.13

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-31.8M
Average Volume	150,704.7x
Bv Per Share	4.26
Ch10y	-99.94
Ch1m	-5.42
Ch1w	0.24
Ch1y	-87.19
Ch3m	0.24
Ch3y	-99.6
Ch5y	-99.15
Ch6m	-62.95
Change	2.2%
Change From Open	0.24
Close	4.1
Days Gap	1.95
Depreciation Amortization	106,627
Dollar Volume	330,859.2
Earnings Date	2026-06-15
Earnings Time	amc
EBIT	$-30.7M
EBITDA	$-30.6M
EPS	$-19.98
F Score	1
FCF	$-31M
FCF EV Yield	-138,309.23x
FCF Per Share	$-4.27
Financing CF	56,145,817
Fiscal Year End	July
Founded	2,014
Investing CF	-288,527
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-10
Last Report Date	2026-01-31
Last Split Date	2025-08-25
Last Split Type	Reverse
Last10k Filing Date	2025-10-16
Ma150	6.98
Ma150ch	-39.98%
Ma20	4.15
Ma20ch	1.09%
Net CF	24,889,974
Next Earnings Date	2026-06-15
Open	4.18
Optionable	Yes
Position In Range	93.33
Post Close	4.19
Postmarket Change Percent	0.03
Postmarket Price	$4.19
Ppne	251,141
Pre Close	4.1
Price Date	2026-05-08
Ptbv Ratio	0.99
Relative Volume	0.52x
Share Based Comp	805,357
Tr6m	-62.95%
Volume	78,964

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BCTX pay a dividend?

Capital-return profile for this ticker.

Performance

BCTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.2%

Float: +88.4% of shares outstanding

Insider ownership

+2.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.4

Neutral momentum band

Price vs 200-day MA

-42.6%

50/200-day relationship not available

Beta (5Y)

1.63

More volatile than the market

Sharpe ratio

-0.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BCTX stock rating?

BriaCell Therapeutics Corp. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BCTX analysis?

The full report lives at /stocks/BCTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BCTX?

The latest report frames BCTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BCTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.